In addition, blocking CD4+ and CD8+ T cell activation in mice with anti-CD40L antibody reduces weight gain, mitigates VAT inflammation, and alleviates obesity-induced IR, also supporting the role of T cell activation in the development of obesity and IR[73,74]. Here, CD4 is linked to obesity disorder.